- Home
- KROS vs DPRO Comparison
KROS vs DPRO Comparison
Compare KROS & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | DPRO |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.0M | 188.8M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KROS | DPRO |
|---|---|---|
| Price | $11.80 | $4.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $21.86 | $15.00 |
| AVG Volume (30 Days) | 318.8K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $243,864,000.00 | N/A |
| Revenue This Year | N/A | $158.69 |
| Revenue Next Year | $2,751.79 | $131.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.69 | $3.23 |
| 52 Week High | $22.55 | $14.37 |
Technical Indicators
Market Signals| Indicator | KROS | DPRO |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 36.02 |
| Support Level | $10.14 | $4.35 |
| Resistance Level | $12.43 | $5.69 |
| Average True Range (ATR) | 0.58 | 0.33 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 70.03 | 5.94 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The two segments are Drones, and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.